BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34011352)

  • 21. BPDAI and ABSIS correlate with serum anti-BP180 NC16A IgG but not with anti-BP230 IgG in patients with bullous pemphigoid.
    Daneshpazhooh M; Ghiasi M; Lajevardi V; Nasiri N; Balighi K; Teimourpour A; Khosravi H; Saeidi V; Mahmoudi H; Chams-Davatchi C
    Arch Dermatol Res; 2018 Apr; 310(3):255-259. PubMed ID: 29423547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoadsorber for specific apheresis of autoantibodies in the treatment of bullous pemphigoid.
    Mersmann M; Dworschak J; Ebermann K; Komorowski L; Schlumberger W; Stöcker W; Zillikens D; Probst C; Schmidt E
    Arch Dermatol Res; 2016 Jan; 308(1):31-8. PubMed ID: 26498290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Respective contribution of neutrophil elastase and matrix metalloproteinase 9 in the degradation of BP180 (type XVII collagen) in human bullous pemphigoid.
    Verraes S; Hornebeck W; Polette M; Borradori L; Bernard P
    J Invest Dermatol; 2001 Nov; 117(5):1091-6. PubMed ID: 11710917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complement-independent blistering mechanisms in bullous pemphigoid.
    Iwata H; Ujiie H
    Exp Dermatol; 2017 Dec; 26(12):1235-1239. PubMed ID: 28418613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimental models for the autoimmune and inflammatory blistering disease, Bullous pemphigoid.
    Leighty L; Li N; Diaz LA; Liu Z
    Arch Dermatol Res; 2007 Nov; 299(9):417-22. PubMed ID: 17879094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune Reaction to Type XVII Collagen Induces Intramolecular and Intermolecular Epitope Spreading in Experimental Bullous Pemphigoid Models.
    Ujiie H; Yoshimoto N; Natsuga K; Muramatsu K; Iwata H; Nishie W; Shimizu H
    Front Immunol; 2019; 10():1410. PubMed ID: 31275329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enzyme-linked immunosorbent assay using multimers of the 16th non-collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies.
    Sitaru C; Dähnrich C; Probst C; Komorowski L; Blöcker I; Schmidt E; Schlumberger W; Rose C; Stöcker W; Zillikens D
    Exp Dermatol; 2007 Sep; 16(9):770-7. PubMed ID: 17697150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of HLA-DRB1, DQA1 and DQB1 alleles and haplotype in Parkinson's disease from South India.
    Pandi S; Chinniah R; Sevak V; Ravi PM; Raju M; Vellaiappan NA; Karuppiah B
    Neurosci Lett; 2021 Nov; 765():136296. PubMed ID: 34655711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid.
    Di Zenzo G; Thoma-Uszynski S; Fontao L; Calabresi V; Hofmann SC; Hellmark T; Sebbag N; Pedicelli C; Sera F; Lacour JP; Wieslander J; Bruckner-Tuderman L; Borradori L; Zambruno G; Hertl M
    Clin Immunol; 2008 Sep; 128(3):415-26. PubMed ID: 18571472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IgE autoantibodies in bullous pemphigoid: supporting role, or leading player?
    Ujiie H
    J Dermatol Sci; 2015 Apr; 78(1):5-10. PubMed ID: 25797172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring mechanisms of IgE-mediated autoimmunity through the lens of bullous pemphigoid.
    Messingham KN; Randall G; Fairley J
    G Ital Dermatol Venereol; 2016 Apr; 151(2):186-97. PubMed ID: 26959553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoreactive Peripheral Blood T Helper Cell Responses in Bullous Pemphigoid and Elderly Patients With Pruritic Disorders.
    Didona D; Scarsella L; Fehresti M; Solimani F; Juratli HA; Göbel M; Mühlenbein S; Holiangu L; Pieper J; Korff V; Schmidt T; Sitaru C; Eming R; Hertl M; Pollmann R
    Front Immunol; 2021; 12():569287. PubMed ID: 33841390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the combination of BP180-NC16a enzyme-linked immunosorbent assay and BP230 enzyme-linked immunosorbent assay in the diagnosis of bullous pemphigoid.
    Yang B; Wang C; Chen S; Chen X; Lu X; Tian H; Yu M; Zhang D; Shi Z; Zhou G; Zhang F
    Indian J Dermatol Venereol Leprol; 2012; 78(6):722-7. PubMed ID: 23075641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of Serum Levels of IgE Autoantibodies Against BP180 With Bullous Pemphigoid Disease Activity.
    van Beek N; Lüttmann N; Huebner F; Recke A; Karl I; Schulze FS; Zillikens D; Schmidt E
    JAMA Dermatol; 2017 Jan; 153(1):30-38. PubMed ID: 27829102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of the Late Onset alzheimer's Disease Associated
    Zhang X; Zou M; Wu Y; Jiang D; Wu T; Zhao Y; Wu D; Cui J; Li G
    Am J Alzheimers Dis Other Demen; 2022; 37():15333175221085066. PubMed ID: 35341343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies.
    Zillikens D; Rose PA; Balding SD; Liu Z; Olague-Marchan M; Diaz LA; Giudice GJ
    J Invest Dermatol; 1997 Oct; 109(4):573-9. PubMed ID: 9326393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IgE autoantibodies against the intracellular domain of BP180.
    Dresow SK; Sitaru C; Recke A; Oostingh GJ; Zillikens D; Gibbs BF
    Br J Dermatol; 2009 Feb; 160(2):429-32. PubMed ID: 18808416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of HLA class II (DRB1, DQA1, DQB1) alleles and haplotypes with myasthenia gravis and its subgroups in the Iranian population.
    Ehsan S; Amirzargar A; Yekaninejad MS; Mahmoudi M; Mehravar S; Moradi B; Nafissi S
    J Neurol Sci; 2015 Dec; 359(1-2):335-42. PubMed ID: 26671138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plectin, an unusual target antigen in bullous pemphigoid.
    Laffitte E; Favre B; Fontao L; Riou S; Jaunin F; Tamm K; Saurat JH; Borradori L
    Br J Dermatol; 2001 Jan; 144(1):136-8. PubMed ID: 11167694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IgG autoantibodies from bullous pemphigoid patients recognize multiple antigenic reactive sites located predominantly within the B and C subdomains of the COOH-terminus of BP230.
    Skaria M; Jaunin F; Hunziker T; Riou S; Schumann H; Bruckner-Tuderman L; Hertl M; Bernard P; Saurat JH; Favre B; Borradori L
    J Invest Dermatol; 2000 May; 114(5):998-1004. PubMed ID: 10771483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.